Sign up
Log in
MARKET
BHC
BHC
Bausch Health Companies Inc
NYSE
5.79
-0.09
-1.53%
Opening 09:42 07/26 EDT
OPEN
5.91
PREV CLOSE
5.88
HIGH
5.91
LOW
5.78
VOLUME
212.60K
TURNOVER
0
52 WEEK HIGH
11.46
52 WEEK LOW
3.960
MARKET CAP
2.12B
P/E (TTM)
-4.6517
1D
5D
1M
3M
1Y
5Y
1D
Bausch Health: Bankruptcy Rumors Scotched For Now, But May Persist
Bausch Health Companies Inc. Stock fell over 40% on bankruptcy rumors yesterday. The company's share price fell by more than 20% after a news article suggested the company was set to file for a Chapter 11 bankruptcy. Bausch denies the claims, and the company's stock price has since recovered some of its losses. The firm's history includes accounting scandals, lawsuits, and financial instability. Despite a $21.5bn debt burden and uncertain future, the company is still worth a look.
Seeking Alpha · 1d ago
Bausch Health Is Maintained at Hold by Truist Securities
Dow Jones · 1d ago
Bausch Health Price Target Cut to $7.00/Share From $8.00 by Truist Securities
Dow Jones · 1d ago
Truist Securities Maintains Hold on Bausch Health Companies, Lowers Price Target to $7
Benzinga · 1d ago
BAUSCH HEALTH COMPANIES INC <BHC.N>: TRUIST SECURITIES CUTS TARGET PRICE TO $7 FROM $8
Reuters · 1d ago
2 Red Alerts On Bausch Health Companies
Rumors circulated on a pre-packaged bankruptcy filing. Bausch Health Companies stock plunged after posting Q1 results. The company's cash flow remains weak, with concerns over long-term debt and limited resources for growth. The stock has a weak earnings per share outlook for Q2.
Seeking Alpha · 1d ago
CANADA STOCKS-Toronto stocks fall as tech selloff counters BoC rate cut
TSX ends down 0.8% at 22,639.57 Tech sector declines 2.2% BoC cuts policy rate to 4.50% Bausch Health Companies Inc is biggest decliner. Bank of Canada cut key interest rate by 25 basis points.
Reuters · 2d ago
BHC Stock Plunges as Bausch Health Appears on the Brink of Bankruptcy
Bausch Health (NYSE:BHC) saw its shares tumble 47% on Wednesday. A report by Reorg claimed the company was on the brink of bankruptcy. Bausch has flatly denied the rumor. The company has $22.07 billion of debt on its books and only $733 million in cash.
Investorplace · 2d ago
About BHC
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.
Webull offers Bausch Health Companies Inc stock information, including NYSE: BHC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BHC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading BHC stock methods without spending real money on the virtual paper trading platform.